Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Immunohistochemistry Analysis of CD44, EGFR, and p16 in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.

Cohen ER, Reis IM, Gomez C, Pereira L, Freiser ME, Hoosien G, Franzmann EJ.

Otolaryngol Head Neck Surg. 2017 Aug;157(2):239-251. doi: 10.1177/0194599817700371. Epub 2017 Apr 11.

PMID:
28397583
2.

A Randomized Double-Blind Placebo-Controlled Trial of Fruit and Vegetable Concentrates on Intermediate Biomarkers in Head and Neck Cancer.

Datta M, Shaw EG, Lesser GJ, Case LD, Vitolins MZ, Schneider C, Frizzell B, Sullivan C, Lively M, Franzmann E, Hu JJ.

Integr Cancer Ther. 2018 Mar;17(1):115-123. doi: 10.1177/1534735416684947. Epub 2017 Jan 19.

3.

Effect of actionable somatic mutations on racial/ethnic disparities in head and neck cancer prognosis.

Wu ES, Park JY, Zeitouni JA, Gomez CR, Reis IM, Zhao W, Kwon D, Lee E, Nelson OL, Lin HY, Franzmann EJ, Savell J, McCaffrey TV, Goodwin WJ, Hu JJ.

Head Neck. 2016 Aug;38(8):1234-41. doi: 10.1002/hed.24420. Epub 2016 Mar 29.

PMID:
27028310
4.

Risk Stratification System for Oral Cancer Screening.

Pereira LH, Reis IM, Reategui EP, Gordon C, Saint-Victor S, Duncan R, Gomez C, Bayers S, Fisher P, Perez A, Goodwin WJ, Hu JJ, Franzmann EJ.

Cancer Prev Res (Phila). 2016 Jun;9(6):445-55. doi: 10.1158/1940-6207.CAPR-15-0200. Epub 2016 Mar 28.

5.

Erratum to: Acceptability of a Rinse Screening Test for Diagnosing Head and Neck Squamous Cell Carcinoma Among Black Americans.

Lechner SC, Pereira L, Reategui E, Gordon C, Byrne M, Hooper MW, Lee DJ, Abouyared M, Franzmann E.

J Racial Ethn Health Disparities. 2015 Mar;2(1):68. doi: 10.1007/s40615-014-0082-7. No abstract available.

PMID:
26863243
6.

Acceptability of a Rinse Screening Test for Diagnosing Head and Neck Squamous Cell Carcinoma Among Black Americans.

Lechner SC, Pereira L, Reategui E, Gordon C, Byrne M, Hooper MW, Lee DJ, Abouyared M, Franzmann E.

J Racial Ethn Health Disparities. 2015 Mar;2(1):62-7. doi: 10.1007/s40615-014-0048-9. Epub 2014 Sep 11. Erratum in: J Racial Ethn Health Disparities. 2015 Mar;2(1):68.

PMID:
26863242
7.

Saliva as a diagnostic tool.

Franzmann E.

MLO Med Lab Obs. 2015 Jul;47(7):24-5. No abstract available.

PMID:
26299145
8.

Biomimetic PEG-catecholates for stabile antifouling coatings on metal surfaces: applications on TiO2 and stainless steel.

Khalil F, Franzmann E, Ramcke J, Dakischew O, Lips KS, Reinhardt A, Heisig P, Maison W.

Colloids Surf B Biointerfaces. 2014 May 1;117:185-92. doi: 10.1016/j.colsurfb.2014.02.022. Epub 2014 Feb 20.

PMID:
24632391
9.

Comments on 'CD44-negative cells in head and neck squamous carcinoma also have stem-cell like traits', Se-Yeong Oh et al., European Journal of Cancer, published online 6 July 2012.

Zheng S, Franzmann EJ.

Eur J Cancer. 2013 Oct;49(15):3380-1. doi: 10.1016/j.ejca.2013.06.031. Epub 2013 Jul 20. No abstract available.

PMID:
23880475
10.

CD44 interacts with EGFR and promotes head and neck squamous cell carcinoma initiation and progression.

Perez A, Neskey DM, Wen J, Pereira L, Reategui EP, Goodwin WJ, Carraway KL, Franzmann EJ.

Oral Oncol. 2013 Apr;49(4):306-13. doi: 10.1016/j.oraloncology.2012.11.009. Epub 2012 Dec 20.

11.

Synthesis of multivalent host and guest molecules for the construction of multithreaded diamide pseudorotaxanes.

Löw NL, Dzyuba EV, Brusilowskij B, Kaufmann L, Franzmann E, Maison W, Brandt E, Aicher D, Wiehe A, Schalley CA.

Beilstein J Org Chem. 2012;8:234-245. doi: 10.3762/bjoc.8.24. Epub 2012 Feb 9.

12.

Salivary protein and solCD44 levels as a potential screening tool for early detection of head and neck squamous cell carcinoma.

Franzmann EJ, Reategui EP, Pereira LH, Pedroso F, Joseph D, Allen GO, Hamilton K, Reis I, Duncan R, Goodwin WJ, Hu JJ, Lokeshwar VB.

Head Neck. 2012 May;34(5):687-95. doi: 10.1002/hed.21810. Epub 2011 Jul 11.

13.

A biomimetic principle for the chemical modification of metal surfaces: synthesis of tripodal catecholates as analogues of siderophores and mussel adhesion proteins.

Franzmann E, Khalil F, Weidmann C, Schröder M, Rohnke M, Janek J, Smarsly BM, Maison W.

Chemistry. 2011 Jul 25;17(31):8596-603. doi: 10.1002/chem.201100715. Epub 2011 Jun 15.

PMID:
21678512
14.

Salivary markers and risk factor data: a multivariate modeling approach for head and neck squamous cell carcinoma detection.

Pereira LH, Adebisi IN, Perez A, Wiebel M, Reis I, Duncan R, Goodwin WJ, Hu JJ, Lokeshwar VB, Franzmann EJ.

Cancer Biomark. 2011;10(5):241-9.

PMID:
22699785
15.

F-18 FDG PET/CT in the assessment of recurrent anaplastic T-cell lymphoma of the external auditory canal.

Gomaa O, Serafini AN, Franzmann E, Kittaneh M, Montague N, Kalkanis D.

Clin Nucl Med. 2010 Aug;35(8):592-4. doi: 10.1097/RLU.0b013e3181e4db98. No abstract available.

PMID:
20631507
16.

A comprehensive analysis of parotid and salivary gland cancer: worse outcomes for male gender.

Cheung MC, Franzmann E, Sola JE, Pincus DJ, Koniaris LG.

J Surg Res. 2011 Nov;171(1):151-8. doi: 10.1016/j.jss.2009.11.721. Epub 2010 Feb 6.

PMID:
20189602
17.

Molecular markers of micrometastasis in oral cavity carcinomas.

Germani RM, Civantos FJ, Elgart G, Roberts B, Franzmann EJ.

Otolaryngol Head Neck Surg. 2009 Jul;141(1):52-8. doi: 10.1016/j.otohns.2009.01.041. Epub 2009 Mar 12.

PMID:
19559958
18.

Elective neck dissection in early-stage oral squamous cell carcinoma.

Sargi ZB, Franzmann EJ.

Head Neck. 2008 Feb;30(2):273-4; author reply 274-5. No abstract available.

PMID:
18098301
19.

Unequal burden of head and neck cancer in the United States.

Goodwin WJ, Thomas GR, Parker DF, Joseph D, Levis S, Franzmann E, Anello C, Hu JJ.

Head Neck. 2008 Mar;30(3):358-71.

PMID:
17972309
20.

Soluble CD44 is a potential marker for the early detection of head and neck cancer.

Franzmann EJ, Reategui EP, Pedroso F, Pernas FG, Karakullukcu BM, Carraway KL, Hamilton K, Singal R, Goodwin WJ.

Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1348-55.

21.

Characterization of CD44v3-containing isoforms in head and neck cancer.

Reategui EP, de Mayolo AA, Das PM, Astor FC, Singal R, Hamilton KL, Goodwin WJ, Carraway KL, Franzmann EJ.

Cancer Biol Ther. 2006 Sep;5(9):1163-8. Epub 2006 Sep 11.

PMID:
16855392
22.
23.

Salivary soluble CD44: a potential molecular marker for head and neck cancer.

Franzmann EJ, Reategui EP, Carraway KL, Hamilton KL, Weed DT, Goodwin WJ.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):735-9.

24.

Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors.

Franzmann EJ, Schroeder GL, Goodwin WJ, Weed DT, Fisher P, Lokeshwar VB.

Int J Cancer. 2003 Sep 1;106(3):438-45.

25.

A novel CD44 v3 isoform is involved in head and neck squamous cell carcinoma progression.

Franzmann EJ, Weed DT, Civantos FJ, Goodwin WJ, Bourguignon LY.

Otolaryngol Head Neck Surg. 2001 Apr;124(4):426-32.

PMID:
11283501

Supplemental Content

Loading ...
Support Center